Pierre Dillard

5PUBLICATIONS
13CO-AUTHORS
Molecular targetsRadiation therapyCancer therapy (excl. chemotherapy and radiation therapy)Tumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jul 08, 2021
Targeting KRAS mutations with HLA class II-restricted TCRs for the treatment of solid tumors.

Pierre Dillard, Nicholas Casey, Sylvie Pollmann

|Nov 29, 2019
Correction to: Preclinical assessment of transiently TCR redirected T cells for solid tumour immunotherapy.

Nadia Mensali, Marit Renée Myhre, Pierre Dillard

|Jun 20, 2019
Preclinical assessment of transiently TCR redirected T cells for solid tumour immunotherapy.

Nadia Mensali, Marit Renée Myhre, Pierre Dillard

|Apr 14, 2019
Preclinical development of CD37CAR T-cell therapy for treatment of B-cell lymphoma.

Hakan Köksal, Pierre Dillard, Sarah E Josefsson

|Feb 07, 2019
Antigen-delivery through invariant chain (CD74) boosts CD8 and CD4 T cell immunity.

Nadia Mensali, Amalie Grenov, Niladri Bhusan Pati

Pageof 1

Frequent Collaborators

5 joint publications

Else Marit Inderberg

4 joint publications

Gustav Gaudernack

4 joint publications

Sébastien Wälchli

3 joint publications

Nadia Mensali